NENCIONI, ALESSIO
 Distribuzione geografica
Continente #
EU - Europa 28.136
AS - Asia 3.448
NA - Nord America 2.397
SA - Sud America 277
AF - Africa 74
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 34.342
Nazione #
IT - Italia 27.525
US - Stati Uniti d'America 2.239
SG - Singapore 1.357
CN - Cina 857
VN - Vietnam 634
FR - Francia 229
BD - Bangladesh 227
BR - Brasile 167
HK - Hong Kong 130
DE - Germania 91
CA - Canada 81
FI - Finlandia 81
AR - Argentina 56
JP - Giappone 49
GB - Regno Unito 47
MX - Messico 40
IN - India 33
IQ - Iraq 30
NL - Olanda 30
CH - Svizzera 25
PH - Filippine 20
ZA - Sudafrica 20
ES - Italia 18
ID - Indonesia 16
PK - Pakistan 16
CL - Cile 13
IE - Irlanda 13
RU - Federazione Russa 13
UA - Ucraina 13
EC - Ecuador 12
TR - Turchia 12
MA - Marocco 11
EG - Egitto 10
JM - Giamaica 10
KE - Kenya 9
SA - Arabia Saudita 9
AU - Australia 8
UZ - Uzbekistan 8
CO - Colombia 7
PY - Paraguay 7
SE - Svezia 7
TW - Taiwan 7
DZ - Algeria 6
PE - Perù 6
PL - Polonia 6
AT - Austria 5
LT - Lituania 5
PA - Panama 5
TH - Thailandia 5
TN - Tunisia 5
AL - Albania 4
DO - Repubblica Dominicana 4
GR - Grecia 4
LB - Libano 4
AE - Emirati Arabi Uniti 3
AF - Afghanistan, Repubblica islamica di 3
AZ - Azerbaigian 3
BE - Belgio 3
GT - Guatemala 3
HR - Croazia 3
JO - Giordania 3
KR - Corea 3
NP - Nepal 3
PT - Portogallo 3
UY - Uruguay 3
VE - Venezuela 3
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
RO - Romania 2
SV - El Salvador 2
AO - Angola 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
GM - Gambi 1
GN - Guinea 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
MG - Madagascar 1
MK - Macedonia 1
Totale 34.326
Città #
Genova 14.599
Genoa 8.237
Rapallo 2.288
Vado Ligure 1.896
Singapore 648
San Jose 638
Ashburn 337
Ho Chi Minh City 202
Lauterbourg 200
Beijing 159
Hanoi 159
New York 131
Hong Kong 123
Council Bluffs 117
Frankfurt am Main 74
Helsinki 74
Los Angeles 68
Santa Clara 65
Milan 53
Bordighera 44
Tokyo 44
Rome 35
Montreal 33
Mexico City 29
Buffalo 26
Chicago 26
Da Nang 25
Haiphong 25
Boardman 24
Dallas 24
Turin 24
Zurich 23
Orem 20
St Louis 20
Phoenix 16
Tianjin 16
Amsterdam 15
City of London 15
São Paulo 15
Biên Hòa 14
Bologna 14
Baghdad 13
Dublin 12
Brooklyn 11
Cardiff 11
Johannesburg 11
Naples 11
Denver 10
Des Moines 10
Can Tho 9
Toronto 9
Atlanta 8
Houston 8
Kingston 8
Kyiv 8
London 8
Miami 8
Phủ Lý 8
Ancona 7
Charlotte 7
Florence 7
Guangzhou 7
Hải Dương 7
Ninh Bình 7
Quảng Ngãi 7
Rio de Janeiro 7
Valenza 7
Bari 6
Buenos Aires 6
Columbus 6
Lappeenranta 6
Madrid 6
Melbourne 6
Mumbai 6
Nairobi 6
Nuremberg 6
Panama City 6
Paris 6
Pittsburgh 6
Santiago 6
Stockholm 6
Tashkent 6
Thái Bình 6
Thái Nguyên 6
Bắc Ninh 5
Cairo 5
Dhaka 5
Guayaquil 5
Karachi 5
La Spezia 5
Las Vegas 5
Long Xuyen 5
Louisville 5
Quezon City 5
Spartanburg 5
Taichung 5
Ankara 4
Birmingham 4
Bordeaux 4
Boston 4
Totale 30.999
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 330
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 318
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. 273
Fasting and cancer: molecular mechanisms and clinical application 266
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 254
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 249
APO866 activity in hematologic malignancies: a preclinical in vitro study. 247
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 245
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents 244
Autophagy in blood cancers: biological role and therapeutic implications. 238
Nicotinic acid phosphoribosyltransferase regulates cancer cell metabolism, susceptibility to NAMPT inhibitors and DNA repair. 236
Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation 235
Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin. 228
The vulnerable coronary plaque: update on imaging technologies. 227
Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics 226
An emerging role of glucagon-like Peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes. 224
Simulation-Based Education for Physicians to Increase Oral Anticoagulants in Hospitalized Elderly Patients with Atrial Fibrillation 223
Update on cardiotoxicity of anti-cancer treatments 222
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 219
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 214
SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells 214
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 209
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. 204
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 203
Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model 202
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 202
SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects 202
Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells 201
Ras-induced resistance to lapatinib is overcome by MEK inhibition 200
Anticancer vaccination strategies. 199
Discovery of novel and selective SIRT6 inhibitors. 199
Delirium, Frailty, and Fast-Track Surgery in Oncogeriatrics: Is There a Link? 198
Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice 197
Sirt6 regulates dendritic cell differentiation, maturation, and function 196
Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters. 194
Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration 194
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 193
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 192
Pathophysiological role of neutrophils in acute myocardial infarction. 191
Fasting potentiates the anticancer activity of tyrosin kinase inhibitors by strenghtening MAPK signalling inhibition. 191
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 190
Algoplus®Scale in Older Patients with Dementia: A Reliable Real-World Pain Assessment Tool 190
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. 189
CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells. 189
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 188
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 188
The In-Hospital Length of Stay after Hip Fracture in Octogenarians: Do Delirium and Dementia Shape a New Care Process? 188
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas. 187
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 185
Differential modulation of SIRT6 deacetylase and deacylase activities by lysine-based small molecules 184
Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments. Concordance with experimental results. 183
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response 183
EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition 182
Appropriateness of prescription of oral anticoagulant therapy in acutely hospitalized older people with atrial fibrillation. Secondary analysis of the SIM-AF cluster randomized clinical trial 182
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 181
Carvedilol Prevents Doxorubicin-induced Free Radical release and Oxidative Damage in Cardiomyocytes. 180
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 180
Evaluating treatment response of chronic myeloid leukemia: emerging science and technology. 178
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 178
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 177
Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA 177
Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors As Therapeutics: Rationales, Controversies, Clinical Experience. 177
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 176
Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 176
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 174
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 174
Systems medicine in oncology: Signaling network modeling and new-generation decision-support systems 173
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents 172
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 172
Evaluation of prognostic indices in elderly hospitalized patients 172
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs 172
Glucagon-Like Peptide-1 Triggers Protective Pathways in Pancreatic Beta-Cells Exposed to Glycated Serum. 170
Frailty assessment in elective gastrointestinal oncogeriatric surgery: Predictors of one-year mortality and functional status 170
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 169
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 168
NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA 167
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 167
The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer. 166
Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques. 166
Nicotinamide Phosphoribosyltransferase As A Target In Inflammation-Related Disorders. 166
Selectivity hot-spots of sirtuin catalytic cores 166
Abstract CT075: Fasting-mimicking diet and hormone therapy modulates metabolic factors to promote breast cancer regression and reduce side effects 166
Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics. 165
The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level 164
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 162
Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells 162
Dual NAMPT and BTK targeting leads to synergistic killing of Waldenström macroglobulinemia cells regardless of MYD88 and CXCR4 somatic mutation status 162
Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8 162
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 160
The use of dendritic cells in cancer immunotherapy. 160
Catastrophic NAD+ Depletion through Nampt Inhibition in Activated T Lymphocytes Reduces Demyelination and Disability in EAE. 159
Immunotherapy with dendritic cells for cancer 159
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 156
NAD+ Levels Control Ca2+ Store Replenishment and Mitogen-induced Increase of Cytosolic Ca2+ by Cyclic ADP-ribose-dependent TRPM2 Channel Gating in Human T Lymphocytes. 156
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases. 156
Synthesis and cancer growth inhibitory activities of 2-fatty-alkylated pyrrolidine-3,4-diol derivatives 155
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 155
Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1 155
Synthesis of Pyrrolidine 3,4-Diol Derivatives with Anticancer Activity on Pancreatic Tumor Cells 153
vitamin C, aging and Alzheimer's disease 152
Totale 19.190
Categoria #
all - tutte 110.434
article - articoli 105.165
book - libri 0
conference - conferenze 2.454
curatela - curatele 0
other - altro 0
patent - brevetti 1.964
selected - selezionate 0
volume - volumi 851
Totale 220.868


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021153 0 0 0 0 0 0 0 0 0 0 0 153
2021/20222.575 76 198 172 338 116 201 133 534 132 249 121 305
2022/20232.793 279 268 35 310 475 387 14 198 414 54 315 44
2023/20241.747 57 178 57 252 189 309 116 115 70 33 109 262
2024/20255.318 234 338 115 405 596 468 515 974 215 270 522 666
2025/202610.045 1.209 325 652 764 1.351 756 1.426 568 789 1.137 728 340
Totale 34.914